Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
06/2009
06/25/2009CA2709862A1 Sinomenine derivatives and processes for their synthesis
06/25/2009CA2709858A1 Process and compounds for the production of (+) opiates
06/24/2009CN101463007A Fluoro or difluoro-2-azabicyclo [2.2.2] octane-3-carboxyl acid derivative and preparation
06/24/2009CN101463006A 2-azabicyclo [2.2.2] octane-3-carboxyl acid derivative and preparation
06/24/2009CN100503575C Helicid hydrastine acetali mine its preparation method and its application
06/24/2009CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
06/23/2009US7550606 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides
06/23/2009US7550595 Bronchodilators for treating chronic obstructive pulmonary disease or asthma; long duration of action; e.g. biphenyl-2-ylcarbamic acid 1-(2-([4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino)ethylpiperidin-4-yl ester; dosage forms such as metered dose inhalers
06/23/2009US7550593 Dissolving finasteride in a solvent, replacing the solvent partially or substantially completely with a non-solvent and thereafter isolating finasteride Form I; 5-alpha reductase inhibitor, for example in the treatment of acne vulgaris, seborrhea, female hirsutism, androgenic alopecia
06/23/2009US7550500 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
06/23/2009US7550478 Tyrosine kinase inhibitors
06/23/2009US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents
06/18/2009US20090156816 Sinomenine derivatives and processes for their synthesis
06/17/2009EP2069308A2 Azonafide derived tumor and cancer targeting compounds
06/17/2009EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/17/2009CN101456842A Synthetic method of phosphoric acid lappaconitine
06/17/2009CN100500656C Metal coordination compound and electroluminescence device
06/16/2009US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders
06/16/2009US7547660 Phenyl-substituted 4-hydroxy-tetrahydropyridones
06/11/2009US20090149488 Tetrahydroprotoberberine Compounds, the Synthetic Method and the Use Thereof
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/10/2009CN100497315C Preparation of (R)-(-)-apomorphine
06/09/2009US7544696 Spermicidal and/or antifungal composition and methods of using the same
06/09/2009US7544215 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds
06/04/2009WO2009069717A1 Azaindenofluorenedione derivative, organic electroluminescent device material, and organic electroluminescent device
06/04/2009WO2009069610A1 Fused indane compound
06/04/2009US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
06/04/2009US20090143417 Methods of treating pain
06/04/2009US20090143389 Heterocyclic inhibitors of mek and methods of use thereof
06/04/2009US20090142618 Oled device employing alkali metal cluster compounds
06/04/2009CA2706171A1 Fused indane compound
06/03/2009EP2064187A2 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
06/03/2009EP2064186A1 Azabicyclic compounds as inhibitors of monoamines reuptake
06/03/2009CN101445482A Method for synthesizing alkaloid
06/03/2009CN100494181C Method for extracting chasmanine from aconitum sungpanense hand-mazz
06/02/2009US7541463 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
06/02/2009US7541365 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
05/2009
05/28/2009WO2009067275A1 N-oxides of 4,5-epoxy-morphinanium analogs
05/28/2009WO2007050383A3 Tyrosine kinase inhibitors
05/28/2009US20090137808 Process for manufacturing bisphosphonic acids
05/28/2009US20090137585 N-acylsulfonamide apoptosis promoters
05/28/2009US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
05/28/2009US20090136779 Conjugated compounds containing hydroindoloacridine structural elements, and their use
05/28/2009CA2706391A1 Spiropiperidines for use as tryptase inhibitors
05/27/2009EP2061765A2 Serine-threonine protein kinase and parp modulators
05/27/2009EP2061461A2 3-azabicyclo[4.1.0]heptane derivatives for the treatment of depression
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009EP1244448B1 Novel methods for the treatment and prevention of ileus
05/27/2009CN101440064A Aconite napelline type diterpene alkaloid acylate, synthesis and use thereof
05/27/2009CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
05/26/2009US7538122 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one
05/26/2009CA2387201C Tetrahydroquinoline derivatives
05/22/2009WO2009064604A1 Acridan derivatives as antioxidants
05/22/2009WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
05/22/2009CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
05/21/2009US20090131435 Heterocyclic inhibitors of mek and methods of use
05/20/2009EP2059505A2 Muscarinic receptor antagonists
05/20/2009EP1270549B1 Polymer-immobilized alpha-iminoester
05/20/2009CN101437516A Treatment of diseases using nalmefene and its analogs
05/20/2009CN101434581A Preparation of aconite primary diterpene alkaloid component and use in disinsection
05/20/2009CN101434580A Mesaconitine acylated product nitrous oxide, preparation and use
05/20/2009CN101434579A Fuziline esterification derivative, synthetic method and use
05/20/2009CN101434578A Synthesis and use of mesaconitine esterification derivative and salt thereof
05/20/2009CN101434577A Method for converting diester type and ester type alkaloid in aconitum Chinese medicine into monoester type alkaloid
05/20/2009CN101434576A Fluorescent fullerene aziridine derivative and preparation thereof
05/19/2009US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives
05/19/2009CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors
05/14/2009WO2009060654A1 Anthrapyridone compound, salt thereof, magenta ink composition and colored body
05/14/2009US20090124651 Catecholamine derivatives and prodrugs thereof
05/14/2009US20090124636 Chemical compounds
05/14/2009US20090121625 Fused heterocyclic compound and organic light emitting device
05/14/2009US20090121620 Organometallic complex, organic el element and organic el display
05/14/2009CA2700044A1 Anthrapyridone compound or salt thereof, magenta ink composition and colored product
05/13/2009EP2058303A1 Method for producing piperidin-4-one-derivative
05/13/2009EP2057123A1 Anthrapyridone compounds
05/13/2009CN101429156A Novel methods for producing 1,2,3,4-tetrahydrochysene-4,4-dimethyl quinoline and its derivant
05/13/2009CN100486976C Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion
05/12/2009US7531658 Reacting 17-carboxylic acid-3-oxo-4-azasteroid with carbonyl- or sulfinyl-diimidazole and amidating the product with an amime in the presence of a heterocyclic hydroxyl activator; avoids the use of expensive and moisture sensitive organomagnesium halide; preparing Finasteride and Dutasteride
05/07/2009WO2009056520A1 Azabicyclo[3.2.1]octane derivatives
05/07/2009WO2009007443A3 New ligands of the benzo[h]quinoline class and transition metal complexes containing them and use of said complexes as catalysts
05/07/2009US20090118321 5-Urea Substituted Naphthalimide Derivatives, Methods of Production and Pharmaceutical Compositions for Treating Cancer
05/07/2009US20090118320 Derivatives of 5,9-methanocycloocta[b]pyridin-2-(1h)-one, their preparation and use as analgesics
05/07/2009US20090118318 Novel Diazaspiroalkanes and Their Use for Treatment of CCR8 Mediated Diseases
05/07/2009US20090118267 Indanes
05/07/2009US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
05/06/2009EP1326865B1 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
05/06/2009CN101426499A Modulators of muscarinic receptors
05/06/2009CN101423495A Method for preparing aconitine hydrolysis monoesters alkaloids
05/05/2009US7528144 N-alkyl-4-amino-1,8-naphthalimides; to visualize, monitor or detect biomolecules; detecting cholesterol trafficking or cholesterol rich domains; INSTANTLYSO LLT-1; no significant cytotoxicity; photostability; very fluorescent in both water and membrane milieu
04/2009
04/30/2009US20090111987 reacting a 11H-indeno[1,2-c]quinolin-11-one derivative with hydroxylamine, then alkylation with an alkyl halide to yield )-11H-indeno[1,2-c]quinolin-11-one oxime derivatives, such as 6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one oxime, used in the treatment of cancers and tumors
04/30/2009US20090111841 Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
04/29/2009CN101417976A Method for preparing aconine from benzoyl
04/29/2009CN101417975A Method for preparing gabapentin intermediate
04/29/2009CN100482677C Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye
04/28/2009US7524966 Associating two or more polyene molecules (1,4-di-4-pyridyl-1,3-butadiene or 1,3,5-tri-4-pyridyl-1,3,5-hexatriene) with a template so that the molecules are properly aligned, and reacting the molecules to form linearly fused cyclobutane rings; the template is preferably a resorcinol derivative
04/28/2009US7524958 Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/28/2009US7524956 Hemisynthetic method and new compounds
04/28/2009US7524912 Preparation of linear ethylene-acrylate copolymers with palladium catalysts and free radical scavengers
04/23/2009WO2006029167A3 Treatment of diseases using nalmefene and its analgos
04/23/2009WO2003025192A3 Membrane transportable fluorescent substrates
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 110